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Mitochondrial DNAThe NLRP3 inﬂammasome, an intracellular multi-protein complex controlling the maturation of cytokine
interleukin-1β, plays an important role in lipopolysaccharide (LPS)-induced inﬂammatory cascades. Recently,
the production of mitochondrial reactive oxygen species (mtROS) in macrophages stimulated with LPS has
been suggested to act as a trigger during the process of NLRP3 inﬂammasome activation that can be blocked
by some mitochondria-targeted antioxidants. Known as a ROS scavenger, molecular hydrogen (H2) has been
shown to possess therapeutic beneﬁt on LPS-induced inﬂammatory damage in many animal experiments.
Due to the uniquemolecular structure, H2 can easily target themitochondria, suggesting that H2 is a potential an-
tagonist of mtROS-dependent NLRP3 inﬂammasome activation. Here we have showed that, in mouse macro-
phages, H2 exhibited substantial inhibitory activity against LPS-initiated NLRP3 inﬂammasome activation by
scavenging mtROS. Moreover, the elimination of mtROS by H2 resultantly inhibited mtROS-mediated NLRP3
deubiquitination, a non-transcriptional priming signal of NLRP3 in response to the stimulation of LPS. Addition-
ally, the removal of mtROS by H2 reduced the generation of oxidized mitochondrial DNA and consequently
decreased its binding to NLRP3, thereby inhibiting the NLRP3 inﬂammasome activation. Our ﬁndings have,
for the ﬁrst time, revealed the novel mechanism underlying the inhibitory effect of molecular hydrogen on
LPS-caused NLRP3 inﬂammasome activation, highlighting the promising application of this new antioxidant in
the treatment of LPS-associated inﬂammatory pathological damage.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Lipopolysaccharide (LPS), the principal component of the outer
membrane of Gram-negative bacteria, is considered as a pivotal trigger
of several inﬂammatory diseases including sepsis and septic shock that
carry substantial morbidity and mortality [1]. LPS can elicit vigorous
production of proinﬂammatory cytokines via the transmembrane toll-
like receptor 4 (TLR4) and subsequently contribute to intracellularterleukin-1 beta; LPS, lipopoly-
ndrial reactive oxygen species;
g 3; TLR4, toll-like receptor 4;
acy, Chengdu Military General
u, Sichuan 610083, PR China.
gy and Intensive CareMedicine,
o. 168, Changhai Road, Yangpu
yi@sina.com (Y. Liu).inﬂammatory cascades [2,3]. There is increasing evidence that the
interleukin-1 beta (IL-1β) driven inﬂammation plays an important
role in the LPS-challenged inﬂammatory condition [4,5]. Due to the
highly pro-inﬂammatory potential, secretion of bioactive IL-1β is tightly
controlled by a caspase-1-mediated process of pro-IL-1β cleavage,
which is regulated by a diverse class of cytosolic multimolecular com-
plexes known as the inﬂammasome [6,7]. Most inﬂammasomes are
named for the Nod-like receptor (NLR) present in the complex, such
as theNLRP1, NLRP3 andNLRC4 [8]. In addition, the inﬂammasome con-
tains the PYHIN (pyrin and HIN domain-containing protein) family
members absent in melanoma 2 (AIM2) called AIM2 inﬂammasome
[9]. Among them, the NLRP3 inﬂammasome is currently themostwide-
ly studied one, capable of mediating a special type of inﬂammatory cell
death termed as pyroptosis in response to LPS via a caspase-1/IL-1β de-
pendent pathway. Although the precise mechanism of LPS to activate
the NLRP3 inﬂammasome still awaits elucidation, recent ﬁndings have
revealed that LPS-induced mitochondrial dysfunction and increasing
production of mitochondrial reactive oxygen species (mtROS) are
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tivation [10,11]. Firstly, LPS-initiated release of mtROS is required for
the deubiquitination of NLRP3, a non-transcriptional priming signal of
NLRP3 inﬂammasome [10]. Furthermore, cells stimulated with LPS can
result in mitochondrial membrane permeabilization and the profound
generation of mtROS, accompaniedwith the oxidation of mitochondrial
DNA (mtDNA). Then the oxidized mtDNA is released into the cytosol
and directly binding to NLRP3, which is regarded as a new molecule to
trigger the secondary signal of NLRP3 activation [12]. Therefore the
new ﬁndings ofmtROS-dependent bipartite activation of NLRP3 accord-
ingly highlight the promising application of known antioxidants with
mtROS-scavenging ability in the treatment of LPS-caused inﬂammatory
pathological damage.
In recent years,molecular hydrogen (H2) has been characterized as a
new antioxidant capable of attenuating the inﬂammatory cascade initi-
ated by LPS [13–15]. Due to its safe and non-toxic properties, either H2
gas or its saturated solution (called H2-rich saline), is increasingly
accepted as a promising candidate in the therapeutic approaches of
LPS-induced pathologic conditions. Early studies have provided evi-
dence that the direct ROS elimination and inhibition on ROS-mediated
oxidative stress are both responsible for the beneﬁcial effects of H2 in
inﬂammatory processes [16,17]. Moreover, other researchers demon-
strated that H2 reduces the LPS-induced sickness behavior and pro-
motes recovery through the regulation of cytokine expression [18]. In
our recent work, it was found that H2 exerted signiﬁcant inhibitory ef-
fect on the NLRP3 inﬂammasome activation in a mouse acute pancrea-
titis model, though it needs to be further determined what the exact
inducer of NLRP3 activation is in the development of acute pancreatitis
[19]. Given the recently described mechanism of LPS-induced NLRP3
activation, our preliminary ﬁnding accordingly triggers an interest in
askingwhether the detoxiﬁcation of LPS by H2 is associatedwith the in-
hibition onmtROS-dependent NLRP3 inﬂammasome activation, for that
H2 is a potential antagonist of mtROS due to its cell-membrane perme-
able property superior to other antioxidants. Obviously, clariﬁcation of
this point will promote a deeper understanding of the detailed mecha-
nism underlying the potential of H2 to attenuate LPS-triggered inﬂam-
matory diseases and draw attention to its promising potential for
clinic application.
2. Materials and methods
2.1. Materials
LPS from Escherichia coli O111:B4, adenosine triphosphate (ATP), rote-
none, Mito-TEMPO, PYR-41 and PR-619 were purchased from Sigma (St.
Louis, MO, USA). Antibodies against the NLRP3, pro-caspase-1, p20 sub-
unit of caspase-1 (casp-1-p20), ubiquitin, 8-hydroxy-2′-deoxyguanosine
(8-OHdG), β-actin and horseradish peroxidase conjugated goat anti-
rabbit antibody were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Enzyme linked immunosorbent assay (ELISA) kits for
IL-1β and 8-OHdG were obtained from R&D system (Minneapolis, MN,
USA) and Cell Biolabs (San Diego, CA, USA), respectively.
HRS was prepared as described previously [19]. In brief, H2 gas
(0.4 mPa) was dissolved in serum-free Dulbecco's modiﬁed eagle's
medium (DMEM) for 6 h to achieve saturated level (0.8 mM), and the
concentration of H2 in medium was detected using a dissolved hydro-
gen analyzer (DH-35A; DKKTOA, Tokyo, Japan). The H2 rich medium
was freshly prepared before use. As a control, the air was treated follow-
ing the same procedure as H2.
2.2. Cells and treatments
MouseRAW264.7 cells (fromAmerican TypeCulture Collection)were
maintained inDMEMsupplementedwith 10% fetal bovine serumat 37 °C
with 5% CO2. Then they were incubated with LPS (500 ng/ml) plus ATP
(5mM) in the absence or presence of various concentrations ofmolecularhydrogen for 4 h at 37 °C, respectively. Cells treatedwith LPS (500 ng/ml)
plus ATP (5 mM) in the air dissolved medium served as a control. More-
over, cells stimulated with the same concentration of LPS plus ATP in the
H2-rich medium (0.8 mM) were further incubated with rotenone
(20 μM), Mito-TEMPO (0.1 mM), PYR-41 (50 μM) or PR-619 (15 μM)
for 4 h at 37 °C, respectively.
2.3. Western blot analysis of NLRP3 inﬂammasome activation
Cells were cultured and treated as described above. Then they were
collected in lysis buffer (0.5% Nonidet P-40, 50 mM HEPES, 0.1 mM
EGTA, 0.1 mM EDTA, 120 mM NaCl, pH 7.5, protease inhibitors). After
centrifuged at 10,000 ×g for 4 min, the lysates and supernatants were
collected. The BCA protein assay kit (Pierce, Rockford, IL, USA) was
employed to determine protein concentration. Proteins in lysates or
supernatants were separated by SDS-polyacrylamide gels followed by
transferring to nitrocellulosemembranes, respectively. Themembranes
were incubated with blocking solution containing 5% skim milk for
more than 1 h at room temperature and probed by 1:1000 dilutions of
rabbit polyclonal antibodies against NLRP3, pro-caspase-1 and casp-1-
p20, respectively. After washing, membranes were incubated with sec-
ondary goat anti-rabbit antibody conjugated to horseradish peroxidase
for 1 h at room temperature. Immunoreactive proteins were visualized
by chemiluminescence using the Western blotting detection system
(Amersham Biosciences, Piscataway, NJ, USA).
2.4. Caspase-1 enzymatic activity assay
After various treatments, cells were lysed in a lysis buffer (20 mM
HEPES, pH 7.5, 1.5 mMMgCl2, 1 mM EDTA, 1 mM EGTA, 0.1 mM PMSF
and protease inhibitor cocktail) for 15 min on ice. After centrifuged at
10,000×g for 4 min, the supernatants were collected and incubated
with 40 μM YVAD-pNA (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), one of the substrates of caspase-1, followed by incubation at
37 °C for 2 h. Then the caspase-1 activity was measured at 405 nm
using a microplate reader.
2.5. Detection of IL-1β concentration
Cells were cultured in DMEM containing 10% fetal bovine serum at
37 °C with 5% CO2 and underwent indicated treatments. After centri-
fuged at 10,000 ×g for 4 min, the supernatants were collected and the
concentrations of IL-1β in the supernatants were analyzed using the
quantitative ELISA kits as instructed by the manufacturer.
2.6. Measurement of mtROS production
The intracellular generation of mtROS was measured using MitoSOX
Red (Invitrogen, Carlsbad, CA, USA), a ﬂuorescent indicator of mitochon-
drial superoxide. Brieﬂy, cells were incubated in a black-walled 96-well
plate with 5 μM MitoSOX Red during the ﬁnal 1 h of treatment as de-
scribed above. After the cells were washed twice with phosphate buff-
ered saline, the plate was read in a microplate ﬂuorescence reader at
510 (excitation) and 580 nm (emission). The increase in mtROS produc-
tion was calculated as the percentage increased compared with control.
2.7. Measurement of oxidized mtDNA generation
To quantitatively analyze the generation of oxidized DNA in themito-
chondria after the stimulation of LPS/ATP, the amount of 8-OHdG, a
marker of oxidized DNA, was measured. In brief, mitochondrial fractions
were isolated from RAW264.7 cells followed by the extraction of mtDNA
using a Mitochondria DNA Isolation Kit (Biovision, San Francisco, CA,
USA) according to the manufacturer's instructions. Then amounts of
8-OHdG in the mtDNA extracts were quantiﬁed using an ELISA kit as
instructed by the manufacturer.
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Cells were cultured in DMEM containing 10% fetal bovine serum at
37 °C with 5% CO2 and underwent indicated treatments. Then cells were
lysed in the immunoprecipitation buffer (1% Nonidet P-40, 0.25% sodium
deoxycholate, 0.1% SDS, 150 mM NaCl, 50 mM Tris, pH 7.5, 2 mM N-
ethylmaleimide, 1 mM NaVO4, 10 mM sodium ﬂuoride, 10 mM sodium
pyrophosphate, 1 mM benzamidine, complete protease inhibitor mix-
ture). The anti-NLRP3 antibody (1:100 dilution) was added to immuno-
precipitate NLRP3 proteins in cell lysates. Then the immunoprecipitates
were subjected to 5.5% SDS-PAGE and electrophoretically transferred
onto nitrocellulose membranes followed by immunoblotting with anti-
ubiquitin (1:500 dilution) or anti-8-OHdG antibody (1:100 dilution), re-
spectively. After washing, membranes were incubated with secondary
antibodies conjugated to horseradish peroxidase for 1 h at room temper-
ature. Immunoreactive proteins were visualized by chemiluminescence
using the Western blotting detection system (Amersham Biosciences,
Piscataway, NJ, USA).
2.9. Statistical and presentation of data
All experimental values were presented as the mean ± SE of three
parallel samples in each group. The data are representative of at least
two independent experiments. Statistical comparisons between groups
were examined by Student's t test. Differences in values were consid-
ered signiﬁcant if p values b 0.05.
3. Results
3.1. Molecular hydrogen dose-dependently inhibited LPS-triggered produc-
tion of mtROS and NLRP3 inﬂammasome activation
The NLRP3 inﬂammasome is an assembled cytosolic protein com-
plex controlling the proteolysis activity of caspase-1, which can cleaveFig. 1.Molecular hydrogen inhibited LPS-inducedmtROS production andNLRP3 inﬂammasome
and casp-1-p20 in RAW264.7 cells were analyzed byWestern blotting. (B) Secreted IL-1β in the c
supernatants was determined using the colorimetric substrate YVAD-pNA at OD 405 nm. (D) In
MitoSOX Red as a ﬂuorescent indicator of mitochondrial superoxide (excitation wavelength: 51
the percentage increased compared with control. The data are representative of at least two indepro-IL-1β into its mature form especially when some types of cells are
co-incubated with LPS and ATP. In present study, we observed that
treatment of LPS/ATP failed to inﬂuence the protein expression of
NLRP3 in a mouse macrophage line, but substantially activated the
NLRP3 inﬂammasome, characterized by increased expression of active
p20 subunit of caspase-1 and enhanced enzymatic activity, as well
as elevated secretion of IL-1β (Fig. 1A, B and C). Meanwhile, pro-
found generation of mtROS in response to LPS stimulation was also
observed as shown in Fig. 1D. Treatment with H2 alone at different
concentrations had no impact on NLRP3 inﬂammasome activity
in control cells (data not shown), but it dose-dependently sup-
pressed the production of maturated IL-1β and mtROS, as well as
the caspase-1 activity in LPS-stimulated cells. These data indicated the
possible relationship between the substantial inhibitory effects of H2
against NLRP3 inﬂammasome activation and the elimination of mtROS
in LPS-stimulated macrophages.3.2. Inhibition of H2 on LPS-induced NLRP3 inﬂammasome activation was
associated with the elimination of mtROS
To further verify whether the mtROS-scavenging ability enabled H2
to block LPS-triggered NLRP3 activation, we examined the changes in
the NLRP3 inﬂammasome activity when cells were challenged with
LPS/ATP in the presence of the mtROS stimulant rotenone or scavenger
Mito-TEMPO, respectively. Here we observed that activity of H2 to sup-
press LPS-initiated NLRP3 inﬂammasome activation was augmented in
the presence of Mito-TEMPO (Fig. 2A and B), andmeanwhile the gener-
ation ofmtROSwas further inhibited (Fig. 2C). In contrast, the treatment
of rotenone inversely elevated the mtROS level and simultaneously
attenuated the inhibitory activity of H2 against NLRP3 activation.
These data further proved that the potential of H2 to suppress NLRP3
inﬂammasome activation was tightly associated with its mtROS-
scavenging activity.activation in a dose-dependentmanner. (A) The protein expression of NLRP3, pro-caspase-1
ell supernatants was quantiﬁed by ELISA. (C) The enzymatic activity of caspase-1 in the cell
tracellular generation of mtROS was measured by a microplate ﬂuorescence reader using
0 nm; emission wavelength: 580 nm). The increase in mtROS production was calculated as
pendent experiments. *p b 0.05, compared to the LPS + ATP group.
Fig. 2. Elimination of mtROS by H2 is required for the inhibition of LPS-induced NLRP3 ac-
tivation. (A) The concentration of IL-1β in the cell supernatants was quantiﬁed by ELISA.
(B) The enzymatic activity of caspase-1 in the cell supernatants was determined using
the colorimetric substrate YVAD-pNA at OD 405 nm. (C) Intracellular generation of
mtROS was measured by a microplate ﬂuorescence reader using MitoSOX Red as a
probe of mitochondrial superoxide (excitation wavelength: 510 nm; emission wave-
length: 580 nm). The increase in mtROS production was calculated as the percentage in-
creased compared with control. The data are representative of at least two independent
experiments. *p b 0.05, compared to the LPS + ATP group. #p b 0.05, compared to the
LPS + ATP group treated with H2 alone.
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to block LPS-induced NLRP3 inﬂammasome activation
Considering previous ﬁndings that mtROS-mediated deubiquiti-
nation of NLRP3 led to the activation of NLRP3 inﬂammasome in LPS/
ATP-challengedmacrophages [10], we next asked if the inhibitory effect
of molecular hydrogen on NLRP3 inﬂammasome activation arise from
its capacity to eliminate mtROS and further block mtROS-dependent
deubiquitination of NLRP3. Firstly, it was observed that in RAW264.7
macrophages H2 exerted signiﬁcant inhibitory effects on LPS-induced
generation of mtROS and concurrently increased the level of NLRP3
ubiquitination, which was further enhanced by the treatment of Mito-
TEMPO (Fig. 3A and B). However, this inhibitory effect was partly abro-
gated upon the treatment of rotenone. These data revealed that the
mtROS-scavenging ability ofmolecular hydrogen rendered its inhibition
onmtROS-dependent deubiquitination of NLRP3. Next, we further eval-
uated whether the activity of H2 to inhibit NLRP3 activation could beaffected by the changes in NLRP3 ubiquitination levels. It was found
that stimulation of macrophages with LPS plus ATP caused notable
deubiquitination of NLRP3 and consequently resulted in the NLRP3
inﬂammasome activation, both of which were signiﬁcantly inhibited
when cells were incubated with H2 (Fig. 3C and D). As expected, the ac-
tivity of H2 against both the deubiquitination and activation of NLRP3
were augmented in the presence of PR-619, a general inhibitor of
deubiquitinating enzyme. In contrast, when LPS-treated macrophages
were co-incubated with PYR-41, an ubiquitin-activating enzyme E1 in-
hibitor capable of blocking the ubiquitination process, the inhibitory ac-
tivity of H2 was attenuated (Fig. 3C and D). These results collectively
suggested that the inhibitory effects of H2 on mtROS and mtROS-
dependent NLRP3 deubiquitination were probably responsible for the
suppression on NLRP3 inﬂammasome activation.
3.4. The mtROS-scavenging ability of H2 was responsible for the inhibition
of oxidized mtDNA primed NLRP3 inﬂammasome activation
It is well-known that mtROS generation usually results in oxidized
mtDNA, which was described as a direct NLRP3 agonist to promote
inﬂammasome assembly [12]. Considering the mtROS-scavenging ac-
tivity of molecular hydrogen, we hypothesized that H2 might probably
possess the capacity to reduce the generation of oxidized mtDNA and
thereby inhibitmtDNA-mediated NLRP3 activation. As expected, our re-
sults showed that treatment with H2 signiﬁcantly reduced the amount
of oxidized mtDNA and inhibited its binding to NLRP3 in macrophages
challenged with LPS/ATP, which was in line with the reduction in
NLRP3 inﬂammasome activity (Fig. 4). In addition, these activities of
H2 were signiﬁcantly weakened or enhanced by the co-culture with ro-
tenone or Mito-TEMPO, respectively. The data substantiate the fact that
changing the amount of mtROS in LPS/ATP-stimulated macrophages
could affect the generation of oxidized mtDNA, as well as its binding
to NLRP3, and might consequently inﬂuence the NLRP3 inﬂammasome
activity.
4. Discussion
In recent years, molecular hydrogen has been considered to be a
promising candidate for the treatment of oxidative stress implicated
diseases in clinical application [16]. As a potential preventive and ther-
apeutic antioxidant, H2 can also be easily administered when dissolved
in water or normal saline, and even used as the solvent for other thera-
peutic agents. Moreover, H2 is quite permeable to biomembranes and
can easily target subcellular organelles, especially the mitochondria
that constitute the biggest source of cellular ROS [20]. As a result, intra-
cellular excessive ROS are scavenged by H2 and the ROS-mediated pro-
inﬂammatory processes are inhibited. Based on our previous ﬁnding
that the NLRP3 inﬂammasome is a potential target of molecular hydro-
gen in an experimental mouse acute pancreatitis model [19], this study
extended our original analysis to evaluate the activity of H2 to inhibit
LPS-stimulatedNLRP3 inﬂammasomeactivation inmousemacrophages
and further reveal the possible mechanism.
Recent researches have provided new insights into the molecular
mechanism regulating the LPS-induced NLRP3 inﬂammasome activa-
tion. In normal condition, the NLRP3 activity is tightly restrained due
to the ubiquitination. However, stimulation of cells with LPS plus ATP
can trigger NLRP3 deubiquitination and abolish this constraint, resulting
in the activation of NLRP3 inﬂammasome [10]. This process was depen-
dent on mtROS production and can be blocked by some antioxidants
[10]. Furthermore, Shimada et al. have reported that oxidized mtDNA,
the ROS-oxidized product released from mitochondria, is capable of
binding and activating NLRP3 inﬂammasome [12]. The ﬁndings above
have offered a hint for the involvement of H2 in regulating the activity
of NLRP3 inﬂammasome after LPS/ATP stimulation. In present study it
was revealed that the inhibitory activity of H2 against the LPS-
triggered NLRP3 inﬂammasome activation was tightly dependent on
Fig. 3. Inhibition of mtROS-dependent NLRP3 deubiquitination was responsible for the blockade of LPS-induced NLRP3 inﬂammasome activation by H2. (A) Intracellular generation of
mtROS was measured by a microplate ﬂuorescence reader using MitoSOX Red (excitation wavelength: 510 nm; emission wavelength: 580 nm). The increase in mtROS production
was calculated as the percentage increased compared with control. (B, C) To evaluate the NLRP3 deubiquitination, cell lysates were immunoprecipitated with anti-NLRP3 antibody and
the bound proteins were further immunoblotted with anti-ubiquitin (anti-Ub) antibody as described inMethods. (D) The enzymatic activity of caspase-1 in the cell supernatants was de-
termined using the colorimetric substrate YVAD-pNA at OD 405 nm (upper panel). Concentration of IL-1β in the cell supernatants was quantiﬁed by ELISA (lower pannel). The data are
representative of at least two independent experiments. *p b 0.05, compared to the LPS + ATP group. #p b 0.05, compared to the LPS + ATP group treated with H2 alone.
Fig. 4.ThemtROS-scavenging ability ofH2 is responsible for the inhibition of oxidizedmtDNA inducedNLRP3 activation. (A) The amount of 8-OHdG in themitochondrial DNA extractswas
measured by ELISA to quantitatively analyze the generation of oxidizedmtDNA. (B) Secreted IL-1β in the cell supernatantswas quantiﬁed by ELISA. (C) To evaluate the binding of 8-OHdG
toNLRP3, cell lysateswere immunoprecipitatedwith anti-NLRP3 antibody and the boundproteinswere further immunoblottedwith anti-8-OHdG antibody. Thedata are representative of
at least two independent experiments. *p b 0.05, compared to the LPS + ATP group. #p b 0.05, compared to the LPS + ATP group treated with H2 alone.
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ously affected by molecules that are able to regulate mtROS production
(e.g. rotenone and Mito-TEMPO). Moreover, our data further revealed
that the LPS-induced generation of oxidized mtDNA and its binding to
NLRP3 were signiﬁcantly blocked by H2, and meanwhile the NLRP3
inﬂammasome activation was suppressed. This process was also tightly
associated with the elimination of mtROS. Therefore, our ﬁndings have
suggested a novelmolecularmechanismunderlying the inhibitory effect
of H2 on the NLRP3 inﬂammasome activation during LPS-associated in-
ﬂammatory processes. In detail, H2 blocks the process of mtROS-
dependent NLRP3 deubiquitination in response to LPS stimulation,
resulting in the impaired NLRP3 inﬂammasome activity. Additionally,
elimination ofmtROS byH2 can also diminish the generation of oxidized
mtDNA and further attenuate its binding to NLRP3, thereby inhibiting
NLRP3 inﬂammasome activation.
Notably, although rotenone stimulated massive production of mtROS
in macrophages under the treatment of LPS plus ATP, it failed to
completely abrogate the inhibitory effect of H2 on NLRP3 inﬂammasome
activation. This ﬁnding suggested that, in addition to themtROS-targeted
pathway, othermechanism(s)might probably enable(s) H2 to inhibit the
LPS-triggered NLRP3 inﬂammasome activation. For example, it was pre-
viously reported that H2 could selectively neutralize peroxynitrite,
a strong oxidant that can degrade the inhibitor of kappaB (I-κB) by
nitrating the tyrosine residues, resulting in the activation of nuclear
factor-κB (NF-κB) [21]. As NF-κB is recently regarded as one of the prim-
ing signals to induce the NLRP3 expression [22], the inhibition of NF-κB
activity following the removal of peroxynitrite likely offers another way
for H2 to suppress the activity of NLRP3 inﬂammasome.
Although the present study has, for the ﬁrst time, shown howmolec-
ular hydrogen acted as a cell protectant against LPS-induced inﬂammato-
ry damage involving the activation of NLRP3 inﬂammasome, there arises
questions need to be further clariﬁed. The ﬁrst, it is known that some
endogenous molecules such as cholesterol, amyloid-β, uric acid and
hyaluronan, have been identiﬁed as the inducers ofNLRP3 inﬂammasome
activation and implicated in some inﬂammation-associated diseases like
atherogenesis, Alzheimer's disease, gout and tissue injury after trauma,
respectively [23–26]. So whether the mechanism underlying the LPS-
induced activation of NLRP3 inﬂammasome is shared by these endoge-
nous molecules remains unanswered. Secondly, can H2 block the NLRP3
inﬂammasome activation triggered by these endogenous molecules
through the same pathway as described in present study? Obviously,
the elucidation of these questions is of considerable signiﬁcance to further
understand the therapeutic potential of molecular hydrogen.
In conclusion, we have evidenced that molecular hydrogen exhibit-
ed substantial mtROS-scavenging capacity, which enables it to block
the NLRP3 inﬂammasome activation by inhibiting mtROS-dependent
NLRP3 deubiquitination and meanwhile by suppressing the generation
of oxidized mitochondrial DNA and its binding to NLRP3. The ﬁndings
in present study may allow for a further understanding of the mecha-
nism underlying the inhibitory effect of molecular hydrogen on LPS-
caused NLRP3 inﬂammasome activation, highlighting the promising
application of this new antioxidant in the treatment of LPS-associated
inﬂammatory pathological damage.
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